Silimed medical devices suspended

Silimed medical devices suspended

The Therapeutic Goods Administration (TGA) is aware of the suspension in Europe of devices manufactured by Silimed that followed an audit of its manufacturing procedures. The TGA is urgently investigating to determine what action is required in Australia including testing of samples.

As a precautionary measure, Device Technologies (the Australian distributor) has stopped any further supply of the products in Australia, and surgeons are being informed and advised to postpone scheduled surgeries.

Patient safety is always our priority. At this time there is no indication that these issues pose a threat to patient safety.

ASPS advises patients who have concerns about their implants to seek advice from their implanting Surgeon.

TGA’s Safety advisory states:

  • Patients are advised to consult their implanting surgeon if they have any concerns
  • TGA is working with professional groups to provide as much information to patients as possible
  • The Brazilian manufacturer was inspected in March 2014 and found to comply with all requirements. The annual re-inspection identified the present issues
  • TGA has had no adverse event reports for these products

Read more: ASPS Media Release (24 Sept 2015)

Media enquiries: Sandra Renowden 0403 823 218 or email

Featured Stories

Associate Professor, Nicola Dean elected President of Australia Society of Plastic Surgeons

Sydney. June 22, 2022: The Australian Society of Plastic Surgeons…

Continue reading

16 March 2022

QLD Journal Club Meeting

Dates for 2022; Wed 16th March Mon 30th May Thurs…

Sally Ng – Why Did You Want To Become A Specialist Plastic Surgeon?

See more

Further Information